Disclosure Of Entity's Operating Segments [Text Block]

ABIONYX Pharma - Filing #2816648

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
675,000 EUR
Profit (loss)
5 822 EUR
5 822 EUR
1 886 EUR
1 886 EUR
Assets
21 832 EUR
10 288 EUR
Cash flows from (used in) operating activities
6 692 EUR
599,000 EUR
Cash flows from (used in) investing activities
1 338 EUR
125,000 EUR
Cash flows from (used in) financing activities
3 972 EUR
1 547 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.